MD (MD)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$2.60B
EV / Sales1.35
EV / EBITDA9.32
EV / Operating Cash Flow10.04
EV / Free Cash Flow10.94

Return Metrics (TTM)

Return on Equity (ROE)20.09%
Return on Assets (ROA)8.42%
Return on Invested Capital (ROIC)9.59%
Return on Capital Employed (ROCE)14.08%

Yield Metrics

Earnings Yield7.91%
Free Cash Flow Yield10.92%

Balance Sheet Strength

Net Debt / EBITDA1.52
Current Ratio1.33
Working Capital$144.40M
Tangible Asset Value-$405.61M
Net Current Asset Value-$604.68M

Working Capital Efficiency

Days Sales Outstanding44.78
Days Payables Outstanding8.03
Operating Cycle (Days)44.78
Cash Conversion Cycle36.75

Capital Allocation

CapEx / Revenue1.11%
CapEx / Operating Cash Flow8.26%
R&D / Revenue0.00%
SG&A / Revenue12.55%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin24.66%
Operating Margin12.07%
Net Profit Margin8.64%

Solvency

Debt / Equity0.76
Quick Ratio1.66
Cash Ratio0.82

Per Share

Revenue / Share$22.45
FCF / Share$2.96
PE Ratio11.03